Publications by authors named "J Okais"
Article Synopsis
- - Eosinophilic fasciitis (EF), also known as Shulman syndrome, is a rare disorder that causes painful swelling and thickening of skin and soft tissues, and can also affect internal organs like the pleura and kidneys.
- - A case report details a 39-year-old patient with unique multifocal skin involvement, discussing symptoms, tissue analysis, possible conditions to consider, treatment options, and the outcomes for the patient.
- - Early diagnosis of EF is essential for effective treatment and improved outcomes, especially when atypical skin lesions are present.
Article Synopsis
- Connective tissue disorders (CTD) associated with interstitial lung disease (ILD) show varied symptoms, complicating their diagnosis and treatment, highlighting the need for early detection.
- A multidisciplinary approach involving collaboration between pulmonologists and rheumatologists is essential for improving patient outcomes in CTD-ILD management.
- A panel of expert rheumatologists created a nine-item questionnaire and a biphasic algorithm to enhance early detection of CTD-ILD, though further research is required to validate this screening tool.
Cricoarytenoid joint arthritis is most frequently reported in Rheumatoid Arthritis and in other systemic diseases such as Sjogren's syndrome, Systemic Lupus Erythematosus, Ankylosing Arthritis, Juvenile Chronic Arthritis, and autoimmune hepatitis but it has not been reported in dermatomyositis. In this paper, we report the case of a 43 years-old woman treated for dermatomyositis who presented with hoarseness and severe odynophagia. The laryngoscopy revealed the presence of an extensive white swelling of the left cricoarytenoid joint with reduced mobility of the left vocal cord, consistent with left cricoarytenoid joint arthritis, which has not previously been described in dermatomyositis to our knowledge.
View Article and Find Full Text PDFBackground: Immune-mediated inflammatory diseases (IMIDs) are chronic conditions that may cause tissue damage and disability, reduced quality of life and increased mortality. Various treatments have been developed for IMIDs, including immune modulators and targeted biologic agents. However, adherence remains suboptimal.
View Article and Find Full Text PDF